📣 VC round data is live. Check it out!

Supriya Lifescience Valuation Multiples

Discover revenue and EBITDA valuation multiples for Supriya Lifescience and similar public comparables like Phathom Pharmaceuticals, LB Pharmaceuticals, Sanofi India, Basilea Pharmaceutica and more.

Supriya Lifescience Overview

About Supriya Lifescience

Supriya Lifescience Ltd is a manufacturer of Active Pharmaceutical Ingredients. It is focused on diverse therapeutic segments such as antihistamines, analgesics, anaesthetics, vitamins, anti-asthmatic, and anti-allergic.


Founded

2008

HQ

India

Employees

515

Financials (LTM)

Revenue: $90M
EBITDA: $31M

EV

$765M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Supriya Lifescience Financials

Supriya Lifescience reported last 12-month revenue of $90M and EBITDA of $31M.

In the same LTM period, Supriya Lifescience generated $31M in EBITDA and $22M in net income.

Revenue (LTM)


Supriya Lifescience P&L

In the most recent fiscal year, Supriya Lifescience reported revenue of $87M and EBITDA of $32M.

Supriya Lifescience is profitable as of last fiscal year, with gross margin of 69%, EBITDA margin of 37%, and net margin of 25%.

See analyst estimates for Supriya Lifescience
LTMLast FY202320242025202620272028
Revenue$90M$87M$56M$68M$83M
Gross Profit-$60M$28M$38M$55M
Gross Margin-69%50%56%67%
EBITDA$31M$32M$18M$26M$31M
EBITDA Margin35%37%33%38%37%
EBIT Margin32%32%28%33%33%
Net Profit$22M$22M$12M$18M$21M
Net Margin25%25%21%26%26%

Financial data powered by Morningstar, Inc.

Supriya Lifescience Stock Performance

Supriya Lifescience has current market cap of $772M, and enterprise value of $765M.

Market Cap Evolution


Supriya Lifescience's stock price is $9.60.

Supriya Lifescience share price decreased by 5.9% in the last 30 days, and increased by 25.3% in the last year.

Supriya Lifescience has an EPS (earnings per share) of $0.27.

See more trading valuation data for Supriya Lifescience
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$765M$772M-13.0%-5.9%58.6%25.3%$0.27

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Supriya Lifescience Valuation Multiples

Supriya Lifescience trades at 8.5x EV/Revenue multiple, and 24.3x EV/EBITDA.

See NTM and 2027E valuation multiples for Supriya Lifescience

EV / Revenue (LTM)


Supriya Lifescience Financial Valuation Multiples

As of June 4, 2026, Supriya Lifescience has market cap of $772M and EV of $765M.

Supriya Lifescience has a P/E ratio of 34.4x.

LTMLast FY202320242025202620272028
EV/Revenue8.5x8.8x13.8x11.3x9.2x
EV/EBITDA24.3x23.9x42.2x29.4x24.7x
EV/EBIT26.8x27.5x49.7x33.8x28.3x
EV/Gross Profit-12.7x27.5x20.0x13.8x
P/E34.4x35.3x66.0x43.2x36.2x
EV/FCF-217.9x(209.8x)n/mn/m

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Supriya Lifescience Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Supriya Lifescience Margins & Growth Rates

Supriya Lifescience grew revenue by 20% and EBITDA by 15% in the last fiscal year.

In the most recent fiscal year, Supriya Lifescience reported gross margin of 69%, EBITDA margin of 37%, and net margin of 25%.

See estimated margins and future growth rates for Supriya Lifescience

Supriya Lifescience Margins

Last FY202420252026202720282029
Gross Margin69%56%67%60%
EBITDA Margin37%38%37%36%
EBIT Margin32%33%33%31%
Net Margin25%26%26%25%
FCF Margin4%(1%)3%4%

Supriya Lifescience Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth20%22%22%20%
Gross Profit Growth-38%45%9%
EBITDA Growth15%43%19%15%
EBIT Growth16%47%19%16%
Net Profit Growth16%53%19%15%
FCF Growth-(82%)(504%)30%

Data powered by FactSet, Inc. and Morningstar, Inc.

Supriya Lifescience Operational KPIs

Supriya Lifescience's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Supriya Lifescience's Rule of 40 is 56% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Supriya Lifescience's Rule of X is 87% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Supriya Lifescience
LTMLast FY202320242025202620272028
Rule of 4056%56%---
Bessemer Rule of X87%87%---
Revenue per Employee-$0.2M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue--4%5%4%
G&A Expenses to Revenue--4%4%4%
Opex to Revenue-37%22%23%34%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Supriya Lifescience Competitors

Supriya Lifescience competitors include Phathom Pharmaceuticals, LB Pharmaceuticals, Sanofi India, Basilea Pharmaceutica, Oneness Biotech, Bright Minds Biosciences, ORIC Pharmaceuticals, Eton Pharmaceuticals, Kura Oncology and HK inno.N.

Most Supriya Lifescience public comparables operate across Biopharmaceuticals, BioTech and DeepTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Phathom Pharmaceuticals4.3x3.1x(5.2x)(9.9x)
LB Pharmaceuticals--(13.8x)-
Sanofi India3.7x3.6x13.7x13.2x
Basilea Pharmaceutica2.3x2.2x10.6x9.7x
Oneness Biotech147.9x-(26.8x)-
Bright Minds Biosciences--(53.8x)(12.1x)
ORIC Pharmaceuticals--(3.6x)(3.4x)
Eton Pharmaceuticals9.5x8.3x45.0x30.2x

This data is available for Pro users. Sign up to see all Supriya Lifescience competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Supriya Lifescience

When was Supriya Lifescience founded?Supriya Lifescience was founded in 2008.
Where is Supriya Lifescience headquartered?Supriya Lifescience is headquartered in India.
How many employees does Supriya Lifescience have?As of today, Supriya Lifescience has over 515 employees.
Is Supriya Lifescience publicly listed?Yes, Supriya Lifescience is a public company listed on National Stock Exchange of India.
What is the stock symbol of Supriya Lifescience?Supriya Lifescience trades under SUPRIYA ticker.
When did Supriya Lifescience go public?Supriya Lifescience went public in 2021.
Who are competitors of Supriya Lifescience?Supriya Lifescience main competitors include Phathom Pharmaceuticals, LB Pharmaceuticals, Sanofi India, Basilea Pharmaceutica, Oneness Biotech, Bright Minds Biosciences, ORIC Pharmaceuticals, Eton Pharmaceuticals, Kura Oncology, HK inno.N.
What is the current market cap of Supriya Lifescience?Supriya Lifescience's current market cap is $772M.
What is the current revenue of Supriya Lifescience?Supriya Lifescience's last 12 months revenue is $90M.
What is the current revenue growth of Supriya Lifescience?Supriya Lifescience revenue growth (NTM/LTM) is 21%.
What is the current EV/Revenue multiple of Supriya Lifescience?Current revenue multiple of Supriya Lifescience is 8.5x.
What is the current EBITDA of Supriya Lifescience?Supriya Lifescience's last 12 months EBITDA is $31M.
What is Supriya Lifescience's EBITDA margin?Supriya Lifescience's last 12 months EBITDA margin is 35%.
What is the current EV/EBITDA multiple of Supriya Lifescience?Current EBITDA multiple of Supriya Lifescience is 24.3x.
How many companies Supriya Lifescience has acquired to date?Supriya Lifescience hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Supriya Lifescience has invested to date?Supriya Lifescience hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Supriya Lifescience

Lists including Supriya Lifescience

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial